跳至主要内容
临床试验/NL-OMON35686
NL-OMON35686已完成不适用

SINGLE-CENTER, OPEN-LABEL STUDY INVESTIGATING THE EXCRETION BALANCE, PHARMACOKINETICS AND METABOLISM OF A SINGLE ORAL DOSE OF [14C]-LABELED RO4917523 AND AN INTRAVENOUS TRACER DOSE OF [13C]-LABELED RO4917523 IN HEALTHY MALE VOLUNTEERS - RO4917523 ADME study

F Hoffmann-La Roche Ltd0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age: 18 - 65 years (inclusive)
  • BMI: 18.0 - 32.0 kg/m2 (inclusive)
  • Gender: healthy male subjects

排除标准

  • Suffering from: hepatitus B, cancer or HIV/AIDS. In case of participation in another study within 60 days before the start of this study or being a blood donor within 90 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior to the start of this study.

研究者

相似试验